Injective
Why Injective is down 1.3% in the last hour
Analysis
Injective (INJ) slipped 1.3% over the past hour as traders digested a regulatory-focused report highlighting Injective’s ambitions around real estate tokenization, which may have prompted short-term caution and profit-taking despite the longer-term growth angle. AMBCrypto noted Injective is “eyeing $10B” in real estate tokenization and framed it through a regulatory lens, which can weigh on near-term sentiment even when the broader narrative is constructive.
Contributing Factors (1)
Injective eyes $10B real estate tokenization – Will INJ demand rise?
Injective [INJ] has been among the tokens that have caught investors’ attention as the blockchain doubles down on its focus on real-world assets (RWAs), which have gained traction recently. Investors...
Move Details
Explanation Confidence
High confidence in the explanation based on source reliability and timing.